Tag: Express Scripts

Express Scripts names Mike Cirillo president of myMatrixx

Express Scripts has announced on Monday that Mike Cirillo will be named the new president of myMatrixx, a pharmacy benefits solutions provider for the massive pharmaceutical company. According to the company, Cirillo will replace Artemis Emslie, who will stay with myMatrixx until the end of May to assist with the transition. Cirillo’s main role within myMatrixx is to ensure that the strategic direction of the company is set, and to help myMatrixx grow the business […]

RELEASE: Express Scripts endorses “Know the Lowest Price Act of 2018” and “Patient Right to Know Drug Prices Act”

ST. LOUIS /PRNewswire/ — Express Scripts (NASDAQ:ESRX) today released this statement in support of S. 2553, the “Know the Lowest Price Act of 2018,” introduced by U.S. Senators Stabenow, Collins, Wyden, Cassidy, McCaskill and Barrasso, and S. 2554, the “Patient Right to Know Drug Prices Act,” introduced by U.S. Senators Collins, McCaskill, Barrasso, Stabenow and Cassidy. Express Scripts is against clawbacks and gag clauses, anti-patient practices that have been used by other pharmacy benefit managers. “Express […]

RELEASE: Express Scripts Holding Company to Cancel Investor Day Meeting

ST. LOUIS, March 14, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts“) announced today it cancelled its previously announced investor day meeting, which was scheduled to be held in New York Cityon May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York.  The cancellation is due to the recent announcement that Cigna and Express Scripts have entered into an Agreement and Plan of Merger. About Express Scripts Express Scripts is […]

RELEASE: Express Scripts awarded national recognition for fighting the opioid epidemic

ST. LOUIS /PRNewswire/ — On Tuesday, Express Scripts (NASDAQ: ESRX) was awarded the Pharmacy Benefit Management Institute’s (PBMI) Excellence Award in the Opioid Management Strategy Category.  The award comes in recognition of the ground breaking ways Express Scripts is helping plan sponsors fight  the serious dangers of opioid misuse and abuse. “PBMI’s recognition of our mission-driven work is validation that we are able to make a real difference in getting patients on a path toward safer […]

RELEASE: Express Scripts Holding Company Announces Webcast of Investor Day Meeting

ST. LOUIS, Feb. 21, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts“) announced today it has scheduled an investor day meeting in New York City on May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York.  At the meeting, senior leaders will discuss the Company’s future outlook, its strategy of creating value for patients and clients and how its innovative tools and solutions position the Company for the future of healthcare. […]

RELEASE: Express Scripts reduces employers’ annual prescription drug spending growth rate to historic low in 2017

ST. LOUIS /PRNewswire/ — At a time when consumers, businesses and policymakers are intensely focused on reducing prescription drug costs, Express Scripts (NASDAQ: ESRX) helped employers reduce the rate of growth in per-person prescription drug spending to 1.5 percent in 2017, according to the 2017 Express Scripts Drug Trend Report released today.  While this growth rate is the lowest Express Scripts has measured since 1993, there is more to be done to make prescription medications more affordable […]

RELEASE: Express Scripts’ Accredo earns renewed URAC specialty pharmacy accreditation

ST. LOUIS /PRNewswire/ — Accredo® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), has earned URAC’s specialty pharmacy accreditation at its primary dispensing locations: Warrendale, Pa., New Castle, Del., Indianapolis, Ind., Orlando, Fla., Memphis, Tenn., Greensboro, N.C., Nashville, Tenn., and Corona, Calif. In addition, Express Scripts Freedom Fertility Pharmacy, located in Byfield, Mass., gained renewal of URAC’s specialty pharmacy accreditation. URAC is a Washington D.C.-based independent accreditor of health care management organizations. To earn its […]

RELEASE: Avista Capital Partners to acquire Express Scripts’ subsidiary United BioSource

ST. LOUIS /PRNewswire/ — Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding Company. Founded in 2003 and headquartered in Blue Bell, Pennsylvania, UBC is a leading provider of pharmaceutical and patient support services, partnering with life science companies to make medicine and medical products safer and more accessible. The company has […]

RELEASE: Express Scripts Holding Company to Present at an Upcoming Conference

ST. LOUIS, Oct. 30, 2017 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts“) announced today that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 7, 2017 at 9:45 a.m. MST (11:45 a.m. EST). The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts’ website at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the broadcast and free […]

RELEASE: Express Scripts Appoints James M. Havel Chief Financial Officer

ST. LOUIS, Oct. 24, 2017 /PRNewswire/ — Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel, who previously served as Express Scripts’ Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017. Eric Slusser, Executive Vice President and Chief Financial Officer, is leaving the Company to pursue other opportunities, but will stay with the Company through the first quarter of 2018 in order to ensure a […]